Centrala Farmaceutyczna Hasco-Leksp. z o.o. in liquidation
Business and other management consultancy activities
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2012-11-07
Share capital
1,000,000.00 PLN
Registered address
Żmigrodzka 242 F, 51-131 Wrocław, Poland
Electronic delivery address
AE:PL-68984-96695-IGAWH-17
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 110 days early. 2 of 6 audited by a statutory auditor.
- 202502/06/2026
- 202418/03/2025
- 202320/03/2024
- 202228/03/2023
- 202116/05/2022
- 202019/03/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 178.89kMedianUSD 66.63kAverageUSD 1.19m
Net profit
This companyUSD 87.36kMedianUSD 1.81kAverageUSD 67.02k
Operating costs
This companyUSD 79.82kMedianUSD 50.39kAverageUSD 1.01m
Assets
This companyUSD 393.43kMedianUSD 69.66kAverageUSD 2.60m
Industry
Authorized Representatives
Gizella Matkowska – Liquidator
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 4,900 | $132,360.89 | 49% | |
| 5,100 | $137,763.37 | 51% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2012-12-06.
31 1090 1522 0000 0001 2018 3956
64 1090 1522 0000 0001 3656 2006
52 1090 1522 0000 0001 2249 3633
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Apr 13, 2026 | Liquidation opened |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $807$807 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $807$807 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Apr 28, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $947$947 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Wrocławska Agencja Rozwoju RegionalnegoS.A. | $2,977,376.24 | warr.pl | ||
| PCCsp. z o.o. | $232,757.69 | pcc1.pl | ||
| Besta Im. Stanisława Tomkówsp. z o.o. | $177,169.08 | besta.wroc.pl | ||
| Sygmasp. z o.o. | $80,653.70 | sygma.pl | ||
| Profescapitalsp. z o.o. | $33,898.14 | redwoodpr.pl | ||
| LBB Budownictwosp. z o.o. | $21,832.79 | legisbud.pl | ||
| SIR Manager Solutionsp. z o.o. | $11,344.53 | sirms.eu | ||
| Recovery SolutionsS.A. | $5,921.15 | recoverysolutions.pl | ||
| Bison ConsultingS.A. | $0.00 | bison-consulting.com.pl | ||
| Grupa4.Comsp. z o.o. | $0.00 | grupa4.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-06-15 | Name change (Centrala Farmaceutyczna Hasco-Lek → Centrala Farmaceutyczna Hasco-Lek Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2026-04-01 | Liquidation opened | |
| 2018-02-09 | PKD change (Removed: 46.45.Z; Added: 77.11.Z) | |
| 2015-06-22 | PKD change (Removed: 46.75.Z, 47.74.Z, 47.75.Z, 52.10.B, 52.24.C) | |
| 2014-07-24 | PKD change (Added: 73.1) |
FAQ
The main business activity of Centrala Farmaceutyczna Hasco-Lek focuses on business and other management consultancy activities.
The company was registered in the Polish National Court Register (KRS) on November 7, 2012.
The headquarters is located at: Żmigrodzka 242 F, 51-131 Wrocław.
The share capital of the company is PLN 1,000,000 (approx. $270,124).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $178,890 in 2025, which is a decrease of 12.6% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of $87,362, meaning the company decreased its profit by 14.7%.
The largest operating cost category falls under employee remuneration. This category amounted to $48,533 in 2025, representing 61% of all operating expenses.
Last updated: 2026-06-15